Cardinal Health, Inc. is highly regarded by UBS and is well-positioned in the healthcare distribution sector. The company's main focus is on distributing pharmaceutical products, which make up 92.6% of its sales.

Medical, surgical, and laboratory products contribute 5.5% to its sales. Cardinal Health is also expanding its manufacturing capabilities for medical and surgical products, including essential items like masks, gowns, gloves, and diagnostic tools. This diversification strategy aims to strengthen its market presence and enhance its product offerings.

The majority of Cardinal Health's sales, approximately 99.3%, come from within the United States, highlighting its significant role in the domestic healthcare supply chain.